Vivo Capital, LLC - COMPASS THERAPEUTICS INC ownership

COMPASS THERAPEUTICS INC's ticker is CMPX and the CUSIP is 20454B104. A total of 35 filers reported holding COMPASS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Vivo Capital, LLC ownership history of COMPASS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7,005,365
-38.1%
3,556,0230.0%0.77%
-1.8%
Q2 2023$11,308,153
-2.8%
3,556,0230.0%0.78%
-3.2%
Q1 2023$11,628,195
+64880.1%
3,556,023
-0.0%
0.81%
-60.8%
Q4 2022$17,895
-99.6%
3,557,630
+77.9%
2.06%
+309.5%
Q3 2022$4,560,000
-14.0%
2,000,0000.0%0.50%
-5.5%
Q2 2022$5,300,000
+93.4%
2,000,0000.0%0.53%
+181.5%
Q1 2022$2,740,000
-56.8%
2,000,0000.0%0.19%
-50.5%
Q4 2021$6,340,0002,000,0000.38%
Other shareholders
COMPASS THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 914,630$2,908,5233.52%
Foresite Capital Management V, LLC 1,324,071$4,210,5463.08%
CHI Advisors LLC 2,829,712$8,998,4842.73%
Monashee Investment Management LLC 1,969,296$6,262,3611.50%
Orbimed Advisors 22,362,850$71,113,8631.29%
Prosight Management, LP 2,167,994$6,894,2201.03%
Vivo Capital, LLC 3,556,023$11,308,1530.78%
BRAIDWELL LP 5,954,273$18,934,5880.62%
Rock Springs Capital Management LP 5,513,788$17,533,8460.42%
CAXTON CORP 43,466$138,2200.40%
View complete list of COMPASS THERAPEUTICS INC shareholders